Suppr超能文献

玫瑰茄的多酚提取物通过减轻体内和体外的线粒体功能障碍来改善对乙酰氨基酚诱导的肝脂肪变性。

A polyphenol extract of Hibiscus sabdariffa L. ameliorates acetaminophen-induced hepatic steatosis by attenuating the mitochondrial dysfunction in vivo and in vitro.

作者信息

Lee Chao-Hsin, Kuo Chih-Yi, Wang Chau-Jong, Wang Chi-Ping, Lee Yi-Ru, Hung Chi-Nan, Lee Huei-Jane

机构信息

Division of Orthopaedics, Lee's Medical Corporation, Taichung Hsien, Taiwan.

出版信息

Biosci Biotechnol Biochem. 2012;76(4):646-51. doi: 10.1271/bbb.110579. Epub 2012 Apr 7.

Abstract

Oxidative stress is the major contributor to acetaminophen (AAP)-caused liver damage. It promotes mitochondrial oxidative stress and collapses the mitochondrial membrane potential to cause cell death. We have previously shown that a polyphenol extract of Hibiscus sabdariffa L. (HPE) potentiated the antioxidative effect. We further examined in this study the possible mechanism of HPE against AAP-caused liver damage. BABL/c mice were orally fed with HPE (100, 200 or 300 mg/kg) for two weeks prior to an i.p. injection of 1000 mg/kg of AAP. The mice were decapitated 6 h after the AAP injection to collect the blood and liver for further determination. The results show that pretreating with HPE increased the level of glutathione (GSH), decreased the level of lipid peroxidation, and increased catalase activity in the liver. A histopathological evaluation shows that HPE could decrease AAP-induced liver sterosis accompanied by a decreased expression of AIF, Bax, Bid, and p-JNK in the liver. An in vitro assay revealed that HPE could reduce AAP-induced death of BABL/c normal liver cells (BNLs), reverse the lost mitochondrial potency and improve the antioxidative status, similarly to the results of the in vivo assay. We show in this study that HPE possessed the ability to protect the liver from AAP-caused injury. The protective mechanism might be regulated by decreasing oxidative stress and attenuating the mitochondrial dysfunction.

摘要

氧化应激是对乙酰氨基酚(AAP)所致肝损伤的主要促成因素。它会促进线粒体氧化应激并破坏线粒体膜电位,从而导致细胞死亡。我们之前已经表明,玫瑰茄多酚提取物(HPE)能增强抗氧化作用。在本研究中,我们进一步探究了HPE对抗AAP所致肝损伤的可能机制。在腹腔注射1000 mg/kg AAP前两周,给BABL/c小鼠口服HPE(100、200或300 mg/kg)。在注射AAP 6小时后,将小鼠断头以采集血液和肝脏用于进一步检测。结果显示,用HPE预处理可提高肝脏中谷胱甘肽(GSH)水平、降低脂质过氧化水平并提高过氧化氢酶活性。组织病理学评估表明,HPE可减轻AAP诱导的肝脏硬化,同时肝脏中凋亡诱导因子(AIF)、Bax、Bid和磷酸化应激活化蛋白激酶(p-JNK)的表达降低。体外试验显示,HPE可减少AAP诱导的BABL/c正常肝细胞(BNLs)死亡,逆转线粒体功能丧失并改善抗氧化状态,这与体内试验结果相似。我们在本研究中表明,HPE具有保护肝脏免受AAP所致损伤的能力。其保护机制可能是通过降低氧化应激和减轻线粒体功能障碍来调节的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验